KOSPI · Healthcare · ₩61B
₩3,8550.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.8% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기 기존 의약품 회복에 수출과 수탁생산이 힘을 보태요.”
In the company's words · 2026 2분기 filing